|
Abstract
August 2005, Vol. 76, No. 8, Pages 1259-1264
, DOI 10.1902/jop.2005.76.8.1259
(doi:10.1902/jop.2005.76.8.1259)
Cyclosporin-Induced Gingival Overgrowth: A Clinical–Epidemiological Evaluation of 121 Italian Renal Transplant Recipients Paolo VescoviOral Pathology and Medicine Unit, Section of Odontostomatology, Department of ENTDental-Ophthalmological and Cervico-Facial Sciences, University of Parma, Parma, Italy. Dr. Marco MeletiOral Pathology and Medicine Unit, Section of Odontostomatology, Department of ENTDental-Ophthalmological and Cervico-Facial Sciences, University of Parma, Parma, Italy. Maddalena ManfrediOral Pathology and Medicine Unit, Section of Odontostomatology, Department of ENTDental-Ophthalmological and Cervico-Facial Sciences, University of Parma, Parma, Italy. Elisabetta MerigoOral Pathology and Medicine Unit, Section of Odontostomatology, Department of ENTDental-Ophthalmological and Cervico-Facial Sciences, University of Parma, Parma, Italy. Giuseppe PedrazziDepartment of Public Health, University of Parma, Parma, Italy. Background: Although other immunosuppressive agents have been recently introduced (e.g., tacrolimus), it has been calculated that in the next decade about 1 million people will still be taking cyclosporin (CsA). The association between gingival overgrowth (GO) and the use of CsA is still not clear. In the present study we evaluated the prevalence and the degree of GO in a group of Italian renal transplant patients and the possible relationship between gingival lesions and demographic, oral, systemic, and pharmacological variables. Methods: One hundred twenty-one renal transplant recipients receiving immunosuppressive therapy with CsA were evaluated in this study. Patients were classified in two groups. In the first (screening group), we included all those patients referred by the Parma University Renal Transplant Center for a general oral checkup, with no specific indications for GO. The second group (non-screening group) included all those patients who specifically had been referred to the Oral Pathology and Oral Medicine Unit because of GO. We considered the following variables: gender, daily CsA dose, duration of immunosuppressive treatment, CsA plasma concentration, concomitant use of another immunosuppressive agent (azathioprine), use of other GO inducers (calcium channel blockers, anti-epileptic drugs), oral hygiene scores, and other drugs taken at the time of oral examination. Results: Fisher's exact test and chi square test demonstrated that in the screening group, duration of immunosuppressive treatment and oral hygiene scores were associated both with the prevalence and the high GO scores (P 1 DIT <0.0001; P 2 DIT = 0.0023; P 1 hyg = 0.0084; P 2 hyg = 0.0068). In the screening group, concomitant use of CsA and azathioprine is related to a low development degree of GO (P = 0.0088). In the non-screening group, we found a significant association between poor oral hygiene and high degree of GO (P = 0.0349). Conclusion: In addition to a probable genetic predisposition, duration of immunosuppressive treatment and oral hygiene status are the most important variables related to development and degree of GO during the use of CsA in this study. J Periodontol 2005;76: 1259-1264. KEYWORDS: Cyclosporin A/adverse effects , dental plaque index , gingival hyperplasia/etiology , immunosuppressive agents/therapeutic use , Italians , periodontal diseases/etiology , renal transplantation/adverse effects Cited byCaroline H. Shiboski, Phyllis Kawada, Megan Golinveaux, Ann Tornabene, Sumathi Krishnan, Robert Mathias, Pamela Den Besten, Philip Rosenthal. (2009) Oral Disease Burden and Utilization of Dental Care Patterns Among Pediatric Solid Organ Transplant Recipients. Journal of Public Health Dentistry 69:1, 48-55 Online publication date: 1-Feb-2009. CrossRef Luís Otávio Miranda Cota, Ana Paula Lima Oliveira, José Eustáquio Costa, Sheila Cavalca Cortelli, Fernando Oliveira Costa. (2008) Gingival Status of Brazilian Renal Transplant Recipients Under Sirolimus-Based Regimens. Journal of Periodontology 79:11, 2060-2068 Online publication date: 1-Nov-2008. Abstract
| Full Text
| PDF (489 KB)
| PDF Plus (563 KB) HYUN-SOOK NAM, JONATHON F. MCANULTY, HO-HYUN KWAK, BYUNG-Il YOON, CHANGBAIG HYUN, WAN-HEE KIM, HEUNG-MYONG WOO. (2008) Gingival Overgrowth in Dogs Associated with Clinically Relevant Cyclosporine Blood Levels: Observations in a Canine Renal Transplantation Model. Veterinary Surgery 37:3, 247-253 Online publication date: 1-May-2008. CrossRef Katja V. Greenberg, Gary C. Armitage, Caroline H. Shiboski. (2008) Gingival Enlargement Among Renal Transplant Recipients in the Era of New-Generation Immunosuppressants. Journal of Periodontology 79:3, 453-460 Online publication date: 1-Mar-2008. Abstract
| Full Text
| PDF (481 KB)
| PDF Plus (549 KB) Fernando Oliveira Costa, Sérgio Diniz Ferreira, Eugênio José Pereira Lages, José Estáquio Costa, Alcione Maria Soares Dutra Oliveira, Luís Otávio Miranda Cota. (2007) Demographic, Pharmacologic, and Periodontal Variables for Gingival Overgrowth in Subjects Medicated With Cyclosporin in the Absence of Calcium Channel Blockers. Journal of Periodontology 78:2, 254-261 Online publication date: 1-Feb-2007. Abstract
| Full Text
| PDF (290 KB)
| PDF Plus (322 KB) ROWAN G WALKER, STEPHEN COTTRELL, KATHLEEN SHARP, ROSAMARIA TRIPODI, KATHY M NICHOLLS, IAN FRASER, GEORGE A VARIGOS, BELINDA E BUTCHER. (2007) Conversion of cyclosporine to tacrolimus in stable renal allograft recipients: Quantification of effects on the severity of gingival enlargement and hirsutism and patient-reported outcomes. Nephrology 12:6, 607 CrossRef Fernando de Oliveira Costa, Sérgio Diniz Ferreira, Luís Otávio de Miranda Cota, José Eustáquio da Costa, Marco Antonio Aguiar. (2006) Prevalence, Severity, and Risk Variables Associated With Gingival Overgrowth in Renal Transplant Subjects Treated Under Tacrolimus or Cyclosporin Regimens. Journal of Periodontology 77:6, 969-975 Online publication date: 1-Jun-2006. Abstract
| Full Text
| PDF (154 KB)
| PDF Plus (214 KB)
|
|
|